News

Glioblastoma Pipeline Appears Promising With 200+ Leading Biotech And Pharma Companies Driving Innovation In The Therapeutics Segment Delveinsight
In July 2025, Inovio Pharmaceuticals conducted a Phase 1/2 trial to evaluate safety, immunogenicity and preliminary efficacy ...